EUVIMEDEUVIMED entdecken
Crossref

Relationship between intrinsic subtypes and tumor responses to neoadjuvant chemotherapy in patients with locally advanced breast cancer

Asako Ooe, Sachiko Takahara, Kazuhiro Sumiyoshi, Hitoshi Yamamoto, Jun Kawai, Eiichi Shiba

Breast Disease · 2013

DOI: 10.3233/bd-130345 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Breast Disease, 2013. Verfasst von Asako Ooe und 5 weiteren Autor:innen. Beteiligte Einrichtung: Osaka Breast Clinic, Osaka, Japan. obc@osaka-breast-clinic.com. Hauptthemen laut MEDLINE: Neoadjuvant Therapy. Die Arbeit wurde bisher 5-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoadjuvant TherapyAdultAgedBreast NeoplasmsFemaleHumansImmunohistochemistryKi-67 AntigenLymphatic MetastasisMagnetic Resonance ImagingMiddle AgedErb-b2 Receptor Tyrosine Kinases

Substanzen

Ki-67 AntigenErb-b2 Receptor Tyrosine KinasesERBB2 protein, human

Autor:innen und Institutionen

  • Osaka Breast Clinic, Osaka, Japan. obc@osaka-breast-clinic.com

Zitieren

APA

Ooe, A., Takahara, S., Sumiyoshi, K., Yamamoto, H., Kawai, J., & Shiba, E. (2013). Relationship between intrinsic subtypes and tumor responses to neoadjuvant chemotherapy in patients with locally advanced breast cancer. Breast Disease. https://doi.org/10.3233/bd-130345

Vancouver

Ooe A, Takahara S, Sumiyoshi K, Yamamoto H, Kawai J, Shiba E. Relationship between intrinsic subtypes and tumor responses to neoadjuvant chemotherapy in patients with locally advanced breast cancer. Breast Disease. 2013. doi:10.3233/bd-130345

BibTeX
@article{Ooe2013,
  author = {Ooe, Asako and Takahara, Sachiko and Sumiyoshi, Kazuhiro and Yamamoto, Hitoshi and Kawai, Jun and Shiba, Eiichi},
  title = {Relationship between intrinsic subtypes and tumor responses to neoadjuvant chemotherapy in patients with locally advanced breast cancer},
  journal = {Breast Disease},
  year = {2013},
  doi = {10.3233/bd-130345}
}
Kostenlos starten →